JNJ-26990990

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C9H10N2O2S2
Molecular Weight	242.318
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of JNJ-26990990

Structure Search

SMILES

NS(=O)(=O)NCC1=CSC2=CC=CC=C12

InChI

InChIKey=AWSKBQNOSRREEY-UHFFFAOYSA-N

InChI=1S/C9H10N2O2S2/c10-15(12,13)11-5-7-6-14-9-4-2-1-3-8(7)9/h1-4,6,11H,5H2,(H2,10,12,13)

HIDE SMILES / InChI

Approval Year

Targets

Targets

Primary Target	Pharmacology	Condition	Potency
Sodium channel protein type II alpha subunit 27 Target ID: CHEMBL4187 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19388676	Inhibitor 8297		48.0 µM [IC50]
Voltage-dependent N-type calcium channel subunit alpha-1B 2 Target ID: Q00975 Gene ID: 774.0 Gene Symbol: CACNA1B Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/19388676	Inhibitor 8297		28.0 µM [IC50]

PubMed

PubMed

Title	Date	PubMed

Name

Type

Language

JNJ-26990990

Common Name

English

N-((BENZO(B)THIEN-3-YL)METHYL)SULFAMIDE

Systematic Name

English

SULFAMIDE, (BENZO(B)THIEN-3-YLMETHYL)-

Systematic Name

English

Code System Code Type Description

PUBCHEM

11687376

Created by admin on Sat Dec 16 09:09:32 GMT 2023 , Edited by admin on Sat Dec 16 09:09:32 GMT 2023

PRIMARY

FDA UNII

QFG58Y96EP

Created by admin on Sat Dec 16 09:09:32 GMT 2023 , Edited by admin on Sat Dec 16 09:09:32 GMT 2023

PRIMARY

WIKIPEDIA

JNJ-26990990

Created by admin on Sat Dec 16 09:09:32 GMT 2023 , Edited by admin on Sat Dec 16 09:09:32 GMT 2023

PRIMARY

CAS

877316-38-6

Created by admin on Sat Dec 16 09:09:32 GMT 2023 , Edited by admin on Sat Dec 16 09:09:32 GMT 2023

PRIMARY

EPA CompTox

DTXSID20470625

Created by admin on Sat Dec 16 09:09:32 GMT 2023 , Edited by admin on Sat Dec 16 09:09:32 GMT 2023

PRIMARY

ACTIVE MOIETY


					QFG58Y96EP

METABOLITE (PARENT)


					WQ36RAD5XB

JNJ-26990990 metabolite M1